Search - tctmd.com

Displaying 1 - 20 of 80

Sort: Relevancy | Date

News Daily News

Adult Survivors of Childhood Cancer May Do Well With Simple Strategy for CV Risk

Caitlin E. Cox

February 13, 2026

News Daily News

Side Effects of Statins Might Be Overstated: CTT Collaboration

Michael O'Riordan

February 12, 2026

News Daily News

Both Low-fat and Low-carb Diets Tied to Less Heart Disease

Michael O'Riordan

February 11, 2026

News Daily News

Heart Disease Remains Number One Killer of Americans

L.A. McKeown

January 22, 2026

News Daily News

JACC Debuts Data Digest on CV Health in the United States

Caitlin E. Cox

January 12, 2026

News Daily News

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Michael O'Riordan

January 08, 2026

News Daily News

Year in Review: Top Prevention Stories of 2025

Michael O'Riordan

December 24, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2025

Caitlin E. Cox

July 31, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

News Daily News

GLP-1s May Stave Off Dementia, EHR-Based Study Shows

Caitlin E. Cox

July 21, 2025

News Daily News

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

L.A. McKeown

January 31, 2025

News Daily News

Top General Cardiology and Prevention News of 2024

Caitlin E. Cox

December 30, 2024

News Daily News

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Yael L. Maxwell

August 16, 2024

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

News Opinion Editor's Corner

Olympic Hearts: Screening for CVD Among Team USA’s Athletes

Michael O'Riordan

July 31, 2024

News Daily News

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Todd Neale

June 26, 2024

News Conference News ACC 2024

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

Michael O'Riordan

April 12, 2024

News Conference News ACC 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

L.A. McKeown

April 06, 2024

News Daily News

High-Risk ‘Clues’ Add Heft to Calcium Scores in Primary Prevention

Michael O'Riordan

February 29, 2024

News Daily News

Who Benefits Most From Semaglutide and How Long Will That Take?

Shelley Wood

December 19, 2023

Advertisement

Adult Survivors of Childhood Cancer May Do Well With Simple Strategy for CV Risk

Side Effects of Statins Might Be Overstated: CTT Collaboration

Both Low-fat and Low-carb Diets Tied to Less Heart Disease

Heart Disease Remains Number One Killer of Americans

JACC Debuts Data Digest on CV Health in the United States

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Year in Review: Top Prevention Stories of 2025

TCTMD’s Top 10 Most Popular Stories for July 2025

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

GLP-1s May Stave Off Dementia, EHR-Based Study Shows

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

Top General Cardiology and Prevention News of 2024

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Olympic Hearts: Screening for CVD Among Team USA’s Athletes

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

High-Risk ‘Clues’ Add Heft to Calcium Scores in Primary Prevention

Who Benefits Most From Semaglutide and How Long Will That Take?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content